Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Sleep Apnea Therapy
NCT03049306Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- Feb 2017
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in obstructive sleep apnea (OSA), sponsored by Johns Hopkins University. Started Feb 2017; status: completed.
02
Drugs
propranolol
03
Conditions
obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT03049306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03049306.